Table 4 Percentages of hemodialysis and peritoneal dialysis patients prescribed specific blood pressure medications within frequently prescribed classes, * 2007–2008
From: Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months
Hemodialysis patients | Peritoneal dialysis patients | |||
|---|---|---|---|---|
Class and medication | Class | Agent | Class | Agent |
Beta blockers | 65.6 | 60.4 | ||
Metoprolol succinate | 25.5 | 32.8 | ||
Metoprolol tartrate | 27.7 | 25.8 | ||
Carvedilol (alpha-beta blocker) | 24.7 | 22.7 | ||
Atenolol | 11.0 | 7.8 | ||
Labetalol (alpha-beta blocker) | 9.1 | 7.0 | ||
% of class represented | 98.0 | 96.1 | ||
ACEIs | 31.4 | 39.6 | ||
Lisinopril | 66.6 | 60.7 | ||
Enalapril | 9.7 | 1.2 | ||
Benazepril | 9.5 | 16.7 | ||
Ramipril | 4.6 | 7.1 | ||
Fosinopril | 4.4 | 4.8 | ||
Quinapril | 4.3 | 7.1 | ||
% of class represented | 99.1 | 97.6 | ||
ARBs | 17.0 | 23.1 | ||
Valsartan | 40.4 | 36.7 | ||
Losartan | 31.4 | 38.7 | ||
Irbesartan | 11.0 | 8.2 | ||
Olmesartan | 9.2 | 4.1 | ||
Telmisartan | 5.3 | 8.2 | ||
Candesartan | 2.7 | 4.1 | ||
% of class represented | 100 | 100 | ||
DHP-CCBs | 43.4 | 39.2 | ||
Amlodipine | 66.2 | 61.4 | ||
Nifedipine | 23.2 | 21.7 | ||
Felodipine | 5.6 | 8.4 | ||
Nisoldipine | 4.0 | 4.8 | ||
% of class represented | 99.0 | 96.3 | ||
Loop diuretics | 29.2 | 45.3 | ||
Furosemide | 84.7 | 89.6 | ||
Bumetanide | 10.4 | 6.3 | ||
Torsemide | 4.9 | 4.2 | ||
% of class represented | 100 | 100 | ||
Central alpha 2 agonist | 19.5 | 12.3 | ||
Clonidine | 98.9 | 96.2 | ||
Methyldopa | 0.8 | 3.8 | ||
% of class represented | 99.7 | 100 | ||
Alpha blockers | 6.6 | 11.8 | ||
Doxazosin | 63.5 | 68.0 | ||
Terazosin | 33.8 | 32.0 | ||
Prazosin | 2.7 | 0.0 | ||
% of class represented | 100 | 100 | ||
Hydralazine | 11.1 | 4.7 | ||
% of class represented | 100 | 100 | ||